| Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells DM Ross, IS Pagani, N Shanmuganathan, CH Kok, JF Seymour, AK Mills, ... Leukemia 32 (12), 2572-2579, 2018 | 80 | 2018 |
| Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia N Shanmuganathan, IS Pagani, DM Ross, S Park, ASM Yong, JA Braley, ... Blood, The Journal of the American Society of Hematology 137 (9), 1196-1207, 2021 | 61 | 2021 |
| Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission IS Pagani, P Dang, VA Saunders, R Grose, N Shanmuganathan, CH Kok, ... Leukemia 34 (4), 1052-1061, 2020 | 44 | 2020 |
| OTX1 expression in breast cancer is regulated by p53 A Terrinoni, IS Pagani, I Zucchi, AM Chiaravalli, V Serra, F Rovera, ... Oncogene 30 (27), 3096-3103, 2011 | 43 | 2011 |
| BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia IS Pagani, P Dang, IO Kommers, JM Goyne, M Nicola, VA Saunders, ... Haematologica 103 (12), 2026, 2018 | 36 | 2018 |
| Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid Leukemia IS Pagani, O Spinelli, E Mattarucchi, C Pirrone, D Pigni, E Amelotti, S Lilliu, ... Oncoscience 1 (7), 510, 2014 | 36 | 2014 |
| Expression of VEGF‐A, Otx homeobox and p53 family genes in proliferative vitreoretinopathy C Azzolini, IS Pagani, C Pirrone, D Borroni, S Donati, M Al Oum, D Pigni, ... Mediators of Inflammation 2013 (1), 857380, 2013 | 26 | 2013 |
| Mechanisms of resistance and implications for treatment strategies in chronic myeloid leukaemia G Poudel, MG Tolland, TP Hughes, IS Pagani Cancers 14 (14), 3300, 2022 | 23 | 2022 |
| The mammary gland and the homeobox gene Otx1 IS Pagani, A Terrinoni, L Marenghi, I Zucchi, AM Chiaravalli, V Serra, ... The breast journal 16, S53-S56, 2010 | 15 | 2010 |
| Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia MA Bassal, SE Samaraweera, K Lim, BA Benard, S Bailey, S Kaur, P Leo, ... Nature communications 13 (1), 2614, 2022 | 13 | 2022 |
| Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia DM Ross, IS Pagani, YD Irani, J Clarson, T Leclercq, P Dang, J McLean, ... British Journal of Haematology 186 (3), e56-e60, 2019 | 10 | 2019 |
| A method for next-generation sequencing of paired diagnostic and remission samples to detect mitochondrial DNA mutations associated with leukemia IS Pagani, CH Kok, VA Saunders, MB Van der Hoek, SL Heatley, ... The Journal of Molecular Diagnostics 19 (5), 711-721, 2017 | 10 | 2017 |
| gDNA Q-PCR for clinical monitoring of CML G Porta, IS Pagani, C Pirrone Cell Cycle 14 (23), 3659-3660, 2015 | 9 | 2015 |
| A gut instinct on leukaemia: A new mechanistic hypothesis for microbiota-immune crosstalk in disease progression and relapse IS Pagani, G Poudel, HR Wardill Microorganisms 10 (4), 713, 2022 | 8 | 2022 |
| Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia IS Pagani, P Dang, VA Saunders, J Braley, A Thieleke, S Branford, ... Leukemia & Lymphoma 61 (10), 2527-2529, 2020 | 7 | 2020 |
| Australasian Leukaemia and Lymphoma Group (ALLG). Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells DM Ross, IS Pagani, N Shanmuganathan, CH Kok, JF Seymour, AK Mills, ... Leukemia 32 (12), 2572-2579, 2018 | 7 | 2018 |
| Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention N Shanmuganathan, C Wadham, NH Shahrin, J Feng, D Thomson, ... Haematologica 108 (9), 2380, 2023 | 4 | 2023 |
| Italian–Australian Scientific and Research Cooperation IS Pagani, T Torresi Italy and Australia: Redefining bilateral relations for the twenty-first …, 2023 | 3 | 2023 |
| Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy IS Pagani, N Shanmuganathan, P Dang, VA Saunders, R Grose, CH Kok, ... Blood 142 (25), 2192-2197, 2023 | 2 | 2023 |
| Long-term follow-up of the ALLG CML8 twister study of treatment-free remission (TFR) in patients with chronic myeloid leukemia (CML) DM Ross, IS Pagani, N Shanmuganathan, JF Seymour, AK Mills, ... Blood 130, 1597, 2017 | 2 | 2017 |
Timothy HughesSAHMRI, University of Adelaide, SA Pathology在 sahmri.com 的电子邮件经过验证
